269 related articles for article (PubMed ID: 26174366)
21. Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis.
Tian Y; Ma Z; Chen Z; Li M; Wu Z; Hong M; Wang H; Svatek R; Rodriguez R; Wang Z
PLoS One; 2016; 11(7):e0158891. PubMed ID: 27410033
[TBL] [Abstract][Full Text] [Related]
22. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
23. A meta-analysis reveals prognostic role of programmed death ligand-1 in Asian patients with non-small cell lung cancer.
Hu XY; Zhang W; Hu Y; Zhang Y; Gong R; Liang JY; Liu L
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):313-320. PubMed ID: 27376797
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis.
Wang X; Zhao H; Lv L; Bao L; Wang X; Han S
Sci Rep; 2016 Jan; 6():19239. PubMed ID: 26754405
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of IGF1R expression in non-small-cell lung cancer.
Nakagawa M; Uramoto H; Oka S; Chikaishi Y; Iwanami T; Shimokawa H; So T; Hanagiri T; Tanaka F
Clin Lung Cancer; 2012 Mar; 13(2):136-42. PubMed ID: 22133293
[TBL] [Abstract][Full Text] [Related]
26. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.
Zhang C; Li J; Han Y; Jiang J
Drug Des Devel Ther; 2015; 9():3267-78. PubMed ID: 26150700
[TBL] [Abstract][Full Text] [Related]
27. Phosphatase and tensin homolog protein may be linked to lymph node metastasis and tumor node metastasis staging in nonsmall cell lung cancer.
Ji ZY; Li HF; Lei Y; Rao YW; Sun ML; Wang XW; Zhang YL
J Cancer Res Ther; 2018; 14(Supplement):S138-S144. PubMed ID: 29578164
[TBL] [Abstract][Full Text] [Related]
28. Ki-67 labeling index is associated with recurrence after segmentectomy under video-assisted thoracoscopic surgery in stage I non-small cell lung cancer.
Yamashita S; Moroga T; Tokuishi K; Miyawaki M; Chujo M; Yamamoto S; Kawahara K
Ann Thorac Cardiovasc Surg; 2011; 17(4):341-6. PubMed ID: 21881319
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma.
Zhao Y; Shi F; Zhou Q; Li Y; Wu J; Wang R; Song Q
Medicine (Baltimore); 2020 Nov; 99(45):e23172. PubMed ID: 33158004
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
31. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
Jao K; Tomasini P; Kamel-Reid S; Korpanty GJ; Mascaux C; Sakashita S; Labbé C; Leighl NB; Liu G; Feld R; Bradbury PA; Hwang DM; Pintilie M; Tsao MS; Shepherd FA
Lung Cancer; 2018 Sep; 123():22-29. PubMed ID: 30089591
[TBL] [Abstract][Full Text] [Related]
32. The roles of CD133 expression in the patients with non-small cell lung cancer.
Wang D; Wen GM; Hou W; Xia P
Cancer Biomark; 2018; 22(3):385-394. PubMed ID: 29758924
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
[TBL] [Abstract][Full Text] [Related]
34. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
Luo Y; Zhang X; Mo M; Tan Z; Huang L; Zhou H; Wang C; Wei F; Qiu X; He R; Chen G
Medicine (Baltimore); 2016 Apr; 95(15):e3337. PubMed ID: 27082587
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer: A protocol for systematic review and meta-analysis.
Chao D; Hu G; Li Q
Medicine (Baltimore); 2021 Feb; 100(7):e24748. PubMed ID: 33607820
[TBL] [Abstract][Full Text] [Related]
36. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients.
Zhang M; Wen F; Zhao K
J Clin Lab Anal; 2021 Aug; 35(8):e23625. PubMed ID: 34216509
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis.
Chen E; Zeng Z; Bai B; Zhu J; Song Z
Oncotarget; 2016 Aug; 7(35):56526-56539. PubMed ID: 27489355
[TBL] [Abstract][Full Text] [Related]
38. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
Feng A; Tu Z; Yin B
Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
[TBL] [Abstract][Full Text] [Related]
39. Expression of p16 in non-small cell lung cancer and its prognostic significance: a meta-analysis of published literatures.
Tong J; Sun X; Cheng H; Zhao D; Ma J; Zhen Q; Cao Y; Zhu H; Bai J
Lung Cancer; 2011 Nov; 74(2):155-63. PubMed ID: 21621871
[TBL] [Abstract][Full Text] [Related]
40. The RET fusion gene and its correlation with demographic and clinicopathological features of non-small cell lung cancer: a meta-analysis.
Lin C; Wang S; Xie W; Chang J; Gan Y
Cancer Biol Ther; 2015; 16(7):1019-28. PubMed ID: 25975578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
